Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Age of Onset as a Moderator of Cognitive Decline in Pediatric-Onset Multiple Sclerosis.
The role of Toll-like receptors in multiple sclerosis and possible targeting for therapeutic purposes.
Is there an association between the Expanded Disability Status Scale and inflammatory markers in multiple sclerosis?
A nexus between lipids and multiple sclerosis?
The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis.
[Autonomic neuropathies].
The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination.
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.
Poppers toxic maculopathy misdiagnosed as atypical optic neuritis.
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis.
Simvastatin Treatment of Patients With Acute Optic Neuritis
The Interdependent, Overlapping, and Differential Roles of Type I and II IFNs in the Pathogenesis of Experimental Autoimmune Encephalomyelitis.
Environmental factors in multiple sclerosis.
Coexistence of peripheral myelin protein 22 and dystrophin mutations in a Chinese boy.
A NOTCH4 missense mutation confers resistance to multiple sclerosis in Japanese.
Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies.
Solifenacin is effective and well tolerated in patients with neurogenic detrusor overactivity: Results from the double-blind, randomized, active- and placebo-controlled SONIC urodynamic study.
Cognitive functioning in pediatric transverse myelitis.
[Multiple sclerosis in Argentina. Systematic review and meta-analysis].
Structural and Dynamical Insights on HLA-DR2 Complexes That Confer Susceptibility to Multiple Sclerosis in Sardinia: A Molecular Dynamics Simulation Study.
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial.
Glia in the pathogenesis of neurodegenerative diseases.
Time to first relapse as an endpoint in multiple sclerosis clinical trials.
S1P1 localizes to the colonic vasculature in ulcerative colitis and maintains blood vessel integrity.
Toll like receptor 2 and 4 expression in peripheral blood mononuclear cells of multiple sclerosis patients.

Pages